More recently, circulating C3 levels have been demonstrated to predict the presence of NAFLD in a large cohort from general population independently of the most plausible confounders such as the presence of metabolic syndrome and obesity. This evidence concerns the gene C3 and metabolic dysfunction-associated steatotic liver disease.